Company intelligence / Profile preview

Chemtron

Shanghai, Shanghai, China

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Chemtron Biotech is a leading developer and manufacturer of rapid diagnostic point-of-care (POCT) products, specializing in lateral flow immunoassay technology. The company offers an extensive portfolio of tests covering infectious diseases, drugs of abuse, fertility, and cardiac markers. Based in Shanghai with a significant presence in the United States, Chemtron provides both proprietary branded products and comprehensive OEM/ODM services to global healthcare providers. In 2020, the company was acquired by Zhejiang Orient Gene Biotech, a move that significantly bolstered its production capacity and market reach. Chemtron's facilities are ISO 13485 certified and many of its products hold CE marks and FDA clearances.

Therapeutic areas: PsychiatryCardiovascularWomen's HealthInfectious Diseases
Modalities: Diagnostic testImmunoassayLateral flow assay
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Chemtron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemtron.

Explore the full profile